|
New Trial to Evaluate Nexavar® as Adjuvant Therapy in Liver Cancer
|
22 August 2008 |
|
Nexavar Approved for Treatment of Liver Cancer in China
|
28 July 2008 |
|
Nexavar Study Demonstrates Significant Improvement in Overall Survival
|
25 July 2008 |
|
Bayer concludes supply and licensing agreements for Yasmin® and YAZ® with Barr for the United Stat
|
24 June 2008 |
|
Bayer HealthCare Commits US-Dollar 2.5 Million in Funding to Advance Global Hemophilia Research
|
04 June 2008 |
|
Nexavar Significantly Extends Overall Survival in Liver Cancer by 47 percent
|
16 May 2008 |
|
International study to evaluate efficacy and safety in treating a leading cause of blindness
|
09 May 2008 |
|
Bayer Schering Pharma to market new low-dose oral contraceptive YAZ® in Europe
|
07 May 2008 |
|
Follicular lymphoma: EU approval for Zevalin® as First-Line Consolidation Treatment
|
28 April 2008 |
|
Bayer Challenges Watson and Sandoz U.S. ANDA Filings on Yasmin®
|
22 April 2008 |
|
Bayer donates €250,000 for patients with hemophilia
|
19 April 2008 |
|
Bayer appeals invalidity ruling on its Yasmin® Patent
|
01 April 2008 |
|
Levitra® - Therapy suitable for men with High Cholesterol
|
26 March 2008 |
|
Zevalin® Receives Positive CHMP Opinion in Europe for First-Line Consolidation Treatment
|
21 March 2008 |
|
Court decides against Bayer's Yasmin® patent
|
04 March 2008 |
|
The Bayer Group once again considerably improved its sales and earnings in 2007
|
28 February 2008 |
|
Bayer and Onyx Provide Update on Phase III Trial of Nexavar®
|
19 February 2008 |
|
Bayer HealthCare Affiliate MEDRAD and Possis Medical Sign Definitive Merger Agreement
|
11 February 2008 |
|
Expanded Labeling for MabCampath® in Europe
|
04 January 2008 |
|
Pivotal Phase III Data Show Superior Efficacy of Rivaroxaban over Enoxaparin
|
10 December 2007 |